JP2021530488A5 - - Google Patents
Info
- Publication number
- JP2021530488A5 JP2021530488A5 JP2021500613A JP2021500613A JP2021530488A5 JP 2021530488 A5 JP2021530488 A5 JP 2021530488A5 JP 2021500613 A JP2021500613 A JP 2021500613A JP 2021500613 A JP2021500613 A JP 2021500613A JP 2021530488 A5 JP2021530488 A5 JP 2021530488A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- heterocyclyl
- pharmaceutical composition
- formula
- composition according
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024052193A JP2024095711A (ja) | 2018-07-12 | 2024-03-27 | 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862696887P | 2018-07-12 | 2018-07-12 | |
| US62/696,887 | 2018-07-12 | ||
| PCT/EP2019/068448 WO2020011804A1 (en) | 2018-07-12 | 2019-07-09 | Alkoxy pyrazoles as soluble guanylate cyclase activators |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024052193A Division JP2024095711A (ja) | 2018-07-12 | 2024-03-27 | 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021530488A JP2021530488A (ja) | 2021-11-11 |
| JP2021530488A5 true JP2021530488A5 (https=) | 2022-07-15 |
| JPWO2020011804A5 JPWO2020011804A5 (https=) | 2022-07-15 |
Family
ID=67314737
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500613A Pending JP2021530488A (ja) | 2018-07-12 | 2019-07-09 | 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール |
| JP2024052193A Pending JP2024095711A (ja) | 2018-07-12 | 2024-03-27 | 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024052193A Pending JP2024095711A (ja) | 2018-07-12 | 2024-03-27 | 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11690848B2 (https=) |
| EP (1) | EP3820470B1 (https=) |
| JP (2) | JP2021530488A (https=) |
| KR (1) | KR20210032443A (https=) |
| CN (1) | CN112384214A (https=) |
| AU (1) | AU2019301887A1 (https=) |
| BR (1) | BR112020025670A2 (https=) |
| CA (1) | CA3103727A1 (https=) |
| CL (1) | CL2021000023A1 (https=) |
| EA (1) | EA202190193A1 (https=) |
| MA (1) | MA53118A (https=) |
| MX (1) | MX2021000405A (https=) |
| PH (1) | PH12021550075A1 (https=) |
| WO (1) | WO2020011804A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118900690A (zh) * | 2022-03-21 | 2024-11-05 | 勃林格殷格翰国际有限公司 | 用于治疗门脉高压的可溶性鸟苷酸环化酶活化剂 |
| WO2024097316A1 (en) | 2022-11-04 | 2024-05-10 | Boehringer Ingelheim International Gmbh | Soluble guanylate cyclase activators for treating systemic sclerosis |
| US20240199590A1 (en) | 2022-12-09 | 2024-06-20 | Boehringer Ingelheim International Gmbh | Solid forms of a sgc activator |
| WO2025036839A1 (en) * | 2023-08-16 | 2025-02-20 | Boehringer Ingelheim International Gmbh | Soluble guanylate cyclase activators for treating clinically significant portal hypertension and decompensated cirrhosis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2748798T3 (es) | 2012-09-07 | 2020-03-18 | Boehringer Ingelheim Int | Alcoxi pirazoles como activadores de la guanilato ciclasa soluble |
| BR112018015718A2 (pt) * | 2016-02-01 | 2019-01-08 | Ironwood Pharmaceuticals Inc | utilização de estimuladores de sgc para o tratamento de esteato-hepatite não alcoólica (nash) |
| US10925876B2 (en) | 2016-05-18 | 2021-02-23 | Merck Sharp & Dohme Corp. | Methods for using triazolo-pyrazinyl soluble guanylate cyclase activators in fibrotic disorders |
-
2019
- 2019-07-09 EP EP19740509.5A patent/EP3820470B1/en active Active
- 2019-07-09 EA EA202190193A patent/EA202190193A1/ru unknown
- 2019-07-09 KR KR1020217004281A patent/KR20210032443A/ko not_active Ceased
- 2019-07-09 CN CN201980045881.XA patent/CN112384214A/zh active Pending
- 2019-07-09 MX MX2021000405A patent/MX2021000405A/es unknown
- 2019-07-09 WO PCT/EP2019/068448 patent/WO2020011804A1/en not_active Ceased
- 2019-07-09 CA CA3103727A patent/CA3103727A1/en active Pending
- 2019-07-09 US US17/258,759 patent/US11690848B2/en active Active
- 2019-07-09 JP JP2021500613A patent/JP2021530488A/ja active Pending
- 2019-07-09 AU AU2019301887A patent/AU2019301887A1/en not_active Abandoned
- 2019-07-09 MA MA053118A patent/MA53118A/fr unknown
- 2019-07-09 BR BR112020025670-6A patent/BR112020025670A2/pt not_active IP Right Cessation
-
2021
- 2021-01-06 CL CL2021000023A patent/CL2021000023A1/es unknown
- 2021-01-12 PH PH12021550075A patent/PH12021550075A1/en unknown
-
2024
- 2024-03-27 JP JP2024052193A patent/JP2024095711A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021530488A5 (https=) | ||
| JP2009533427A5 (https=) | ||
| CN113365998A (zh) | 用于parp抑制剂的吲哚并七元酰肟类似物 | |
| JP2019094345A5 (https=) | ||
| AU2017276170A1 (en) | Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of Hepatitis B | |
| JPWO2020123827A5 (https=) | ||
| HRP20141048T1 (hr) | Spojevi, pripravci i metode | |
| RU2006134020A (ru) | Конденсированные производные пиразола | |
| JP2017518959A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| JP2016512202A5 (https=) | ||
| JP2020532550A5 (https=) | ||
| RU2001120726A (ru) | Комбинация ингибиторов fbpазы и сенсибилизаторов инсулина для лечения диабета | |
| JP2018529671A5 (https=) | ||
| JP2003515523A5 (https=) | ||
| JPWO2019148044A5 (https=) | ||
| JP2020518571A5 (https=) | ||
| CN111655678A (zh) | 细胞凋亡信号调节激酶-1抑制剂及其应用 | |
| JP2024095711A (ja) | 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール | |
| JP2021533206A5 (https=) | ||
| JP2021528451A5 (https=) | ||
| JP2019537577A5 (https=) | ||
| JPWO2020011804A5 (https=) | ||
| JPWO2022034568A5 (https=) | ||
| JP2019522673A5 (https=) |